Skip to Main Content
Table 1—

Baseline characteristics of patients with diabetes

Baseline characteristic (at randomization)Atorvastatin 10 mgAtorvastatin 80 mg
n 753 748 
Men 544 (72.2) 550 (73.5) 
Age (years) 62.8 ± 8.0 63.2 ± 7.9 
Race   
    White 670 (89.0) 670 (89.6) 
    Black 48 (6.4) 39 (5.2) 
    Other 35 (4.6) 39 (5.2) 
Systolic blood pressure (mmHg) 134.7 ± 17.3 134.3 ± 17.6 
Diastolic blood pressure (mmHg) 76.8 ± 9.5 77.1 ± 9.9 
BMI (kg/m230.7 ± 5.6 30.1 ± 5.0 
Diabetes duration (years) 8.3 ± 8.5 8.8 ± 8.8 
Diabetes control   
    Oral hypoglycemic drug only 324 (43.0) 326 (43.6) 
    Insulin only 101 (13.4) 94 (12.6) 
    Insulin + oral hypoglycemic drug 157 (20.8) 146 (19.5) 
    No diabetes medications* 171 (22.7) 182 (24.3) 
    Fasting plasma glucose (mg/dl) 153.9 ± 49.3 154.0 ± 49.9 
    Plasma creatinine (mg/dl) 1.19 ± 0.23 1.19 ± 0.25 
    A1C (%) 7.4 ± 1.3 7.4 ± 1.2 
Cardiovascular history   
    Angina 606 (80.5) 632 (84.5) 
    Hypertension 536 (71.2) 525 (70.2) 
    Former smoker 484 (64.3) 446 (59.6) 
    Myocardial infarction 414 (55.0) 442 (59.1) 
    Coronary artery bypass graft 420 (55.8) 403 (53.9) 
    Coronary angioplasty 370 (49.1) 402 (53.7) 
    Peripheral arterial disease 151 (20.1) 168 (22.5) 
    Congestive heart failure 105 (13.9) 108 (14.4) 
    Current smoker 72 (9.6) 86 (11.5) 
    Cerebrovascular accident 67 (8.9) 68 (9.1) 
Lipids   
    LDL cholesterol   
        mg/dl 96.7 ± 17.8 95.6 ± 18.4 
        mmol/l 2.50 ± 0.46 2.47 ± 0.48 
    Total cholesterol   
        mg/dl 174.9 ± 24.5 174.7 ± 24.6 
        mmol/l 4.52 ± 0.63 4.52 ± 0.64 
    Triglycerides   
        mg/dl 169.2 ± 78.9 171.3 ± 80.9 
        mmol/l 1.91 ± 0.89 1.93 ± 0.91 
    HDL cholesterol   
        mg/dl 44.6 ± 9.2 45.2 ± 11.1 
        mmol/l 1.15 ± 0.24 1.17 ± 0.29 
    Apolipoprotein B 113.6 ± 20.0 112.5 ± 19.5 
Baseline characteristic (at randomization)Atorvastatin 10 mgAtorvastatin 80 mg
n 753 748 
Men 544 (72.2) 550 (73.5) 
Age (years) 62.8 ± 8.0 63.2 ± 7.9 
Race   
    White 670 (89.0) 670 (89.6) 
    Black 48 (6.4) 39 (5.2) 
    Other 35 (4.6) 39 (5.2) 
Systolic blood pressure (mmHg) 134.7 ± 17.3 134.3 ± 17.6 
Diastolic blood pressure (mmHg) 76.8 ± 9.5 77.1 ± 9.9 
BMI (kg/m230.7 ± 5.6 30.1 ± 5.0 
Diabetes duration (years) 8.3 ± 8.5 8.8 ± 8.8 
Diabetes control   
    Oral hypoglycemic drug only 324 (43.0) 326 (43.6) 
    Insulin only 101 (13.4) 94 (12.6) 
    Insulin + oral hypoglycemic drug 157 (20.8) 146 (19.5) 
    No diabetes medications* 171 (22.7) 182 (24.3) 
    Fasting plasma glucose (mg/dl) 153.9 ± 49.3 154.0 ± 49.9 
    Plasma creatinine (mg/dl) 1.19 ± 0.23 1.19 ± 0.25 
    A1C (%) 7.4 ± 1.3 7.4 ± 1.2 
Cardiovascular history   
    Angina 606 (80.5) 632 (84.5) 
    Hypertension 536 (71.2) 525 (70.2) 
    Former smoker 484 (64.3) 446 (59.6) 
    Myocardial infarction 414 (55.0) 442 (59.1) 
    Coronary artery bypass graft 420 (55.8) 403 (53.9) 
    Coronary angioplasty 370 (49.1) 402 (53.7) 
    Peripheral arterial disease 151 (20.1) 168 (22.5) 
    Congestive heart failure 105 (13.9) 108 (14.4) 
    Current smoker 72 (9.6) 86 (11.5) 
    Cerebrovascular accident 67 (8.9) 68 (9.1) 
Lipids   
    LDL cholesterol   
        mg/dl 96.7 ± 17.8 95.6 ± 18.4 
        mmol/l 2.50 ± 0.46 2.47 ± 0.48 
    Total cholesterol   
        mg/dl 174.9 ± 24.5 174.7 ± 24.6 
        mmol/l 4.52 ± 0.63 4.52 ± 0.64 
    Triglycerides   
        mg/dl 169.2 ± 78.9 171.3 ± 80.9 
        mmol/l 1.91 ± 0.89 1.93 ± 0.91 
    HDL cholesterol   
        mg/dl 44.6 ± 9.2 45.2 ± 11.1 
        mmol/l 1.15 ± 0.24 1.17 ± 0.29 
    Apolipoprotein B 113.6 ± 20.0 112.5 ± 19.5 

Data are means ± SD or n (%).

*

Patients who were not recorded as taking oral hypoglycemic agents or insulin at study entry.

Close Modal

or Create an Account

Close Modal
Close Modal